title: NAD dependent 11beta-hydroxysteroid dehydrogenase activity in human endometrium and endometrial tumors.
abstract: BACKGROUND
  The isoforms of 11beta-hydroxysteroid dehydrogenase (11beta-HSD) types 1 and 2, regulated by ovarian steroids, catalyze the interconversion of glucocorticoids and their 11-keto metabolites. The role of these enzymes in malignancies of human endometrium is unknown. We compare NAD dependent 11beta-HSD (type 2) activity levels among normal human endometrium and endometrial carcinomas of differing grades and histologies.
  
  
  METHODS
  NAD dependent 11beta-HSD activity was determined in endometrial tissue obtained from patients undergoing hysterectomy for benign or malignant disease (endometroid, serous and carcinosarcomas). Student's t test was utilized with p < 0.05 considered significant. Data are presented as mean +/- SD.
  
  
  RESULTS
  NAD dependent 11beta-HSD activity was present in all endometrial samples. The activities were 0.61+/- 0.27 in normal (n = 9), 0.43 +/- 0.29 in endometrioid endometrial carcinoma (n = 14), 0.50 +/- 0.26 in uterine serous carcinoma (n = 6) and 0.25 +/- 0.37 in carcinosarcomas (n = 9). NAD dependent 11beta-HSD activity was lower in the carcinosarcoma group as compared to normal endometrial tissue (p = 0.03).
  
  
  CONCLUSIONS
  NAD dependent type 2 11beta-HSD activity was demonstrated in all normal and endometrial tumors. Enzyme activity in endometroid and uterine serious carcinoma tumors was similar to enzyme activity in normal endometrium. In contrast, carcinosarcomas show significantly lower enzyme activity compared to normal tissue.
authors.affiliation: Department of Obstetrics and Gynecology, The Division of Gynecologic Oncology, State University of New York, Downstate Medical Center, Brooklyn, NY 11203, USA.
authors.forename: Tsatsas
authors.initials: T
authors.lastname: Manolis
authors.forename: Yi-Chun
authors.initials: YC
authors.lastname: Lee
authors.forename: Sarah
authors.initials: S
authors.lastname: Temkin
authors.forename: Mira
authors.initials: M
authors.lastname: Hellman
authors.forename: Vijaya L
authors.initials: VL
authors.lastname: Nacharaju
authors.forename: Ovadia
authors.initials: O
authors.lastname: Abulafia
mesh_terms: D043209:11-beta-Hydroxysteroid Dehydrogenase Type 2 / Q000378:metabolism*; D002277:Carcinoma / Q000201:enzymology*; D002296:Carcinosarcoma / Q000201:enzymology*; D016889:Endometrial Neoplasms / Q000201:enzymology*; D004717:Endometrium / Q000201:enzymology*; D005260:Female; D006801:Humans; D007044:Hysterectomy; D009367:Neoplasm Staging
chemical_list: D043209:11-beta-Hydroxysteroid Dehydrogenase Type 2